Forest Laboratories, Inc.
Forest Laboratories, Inc. Reports Q3'09 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees
Published in Lab Business Week, February 8th, 2009
Forest Laboratories, Inc. (NYSE:FRX), a U.S. based pharmaceutical company, announced that reported diluted earnings per share equaled $0.62 in the third quarter of fiscal year 2009. Reported earnings per share include charges for new product licensing fees of $150,000,000, or $0.41 per share net of tax, related to the previously announced product collaboration agreements with Phenomix Corporation (Phenomix) for dutogliptin for the treatment of diabetes and Pierre Fabre Medicament (Pierre Fabre) for F2695 for the treatment of depression. Reported diluted earnings per share in the third quarter of fiscal 2008 were $0.96. Excluding the net of tax impact of the two licensing charges, diluted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2009-02-08)
More Articles from Lab Business Week
- Idexx Laboratories, Inc.
IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results - National Labor Relations Board
Wilma Liebman Designated NLRB Chairman - Newhall Laboratories, Inc.
Parent Company of La Bella and Real Solutions Beauty Lines Announces New President and CEO - Pennsylvania Department of Labor & Industry
Rendell Administration Hails Volunteers Building on Dr. King's Legacy - Pennsylvania Department of Labor & Industry
Unemployment Compensation Claims Can Be Filed Online on Martin Luther King Holiday - U.S. Department of Labor
U.S. Department of Labor awards $250,000 to establish economic strategy for western Kentucky and surrounding areas in Tennessee and Illinois - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
